These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28752674)
1. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population. Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674 [TBL] [Abstract][Full Text] [Related]
2. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma. Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A Front Immunol; 2018; 9():926. PubMed ID: 29765374 [TBL] [Abstract][Full Text] [Related]
3. Association study of MICA gene polymorphisms with rheumatoid arthritis susceptibility in south Tunisian population. Achour Y; Kammoun A; Ben Hamad M; Mahfoudh N; Chaabane S; Marzouk S; Keskes L; Gaddour L; Bahloul Z; Maalej A Int J Immunogenet; 2014 Dec; 41(6):486-92. PubMed ID: 25256191 [TBL] [Abstract][Full Text] [Related]
4. Functional MICA-129 polymorphism and serum levels of soluble MICA are correlated with ulcerative colitis in Chinese patients. Zhao J; Jiang Y; Lei Y; Zou K; Wang C; Huang S; Yi F; Xia B J Gastroenterol Hepatol; 2011 Mar; 26(3):593-8. PubMed ID: 21155878 [TBL] [Abstract][Full Text] [Related]
5. [The relationship between major histocompatibility complex class I chain-related antigens A (MICA)-129 gene polymorphism, soluble MICA level and ulcerative colitis]. Zhao J; Jiang Y; Lei Y; Chen LP; Yi FM; Wang CG; Zou KF; Xia B Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):311-5. PubMed ID: 21600151 [TBL] [Abstract][Full Text] [Related]
6. Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis. Mariaselvam CM; Tamouza R; Krishnamoorthy R; Charron D; Misra DP; Jain VK; Negi VS Clin Exp Immunol; 2017 Mar; 187(3):369-375. PubMed ID: 27783394 [TBL] [Abstract][Full Text] [Related]
7. MICA-129 A/G dimorphism, its relation to soluble mica plasma level and spontaneous preterm birth: A case-control study. Von Linsingen R; Gelmini GF; Bicalho MDG; De Carvalho NS J Reprod Immunol; 2018 Sep; 129():9-14. PubMed ID: 30025372 [TBL] [Abstract][Full Text] [Related]
8. Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis. Iwaszko M; Świerkot J; Dratwa M; Wysoczańska B; Korman L; Bugaj B; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K Pharmacogenomics J; 2020 Dec; 20(6):760-769. PubMed ID: 32123296 [TBL] [Abstract][Full Text] [Related]
9. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population. Mariaselvam CM; Fortier C; Charron D; Krishnamoorthy R; Tamouza R; Negi VS HLA; 2016 Nov; 88(5):253-258. PubMed ID: 27753285 [TBL] [Abstract][Full Text] [Related]
10. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Boukouaci W; Busson M; Peffault de Latour R; Rocha V; Suberbielle C; Bengoufa D; Dulphy N; Haas P; Scieux C; Amroun H; Gluckman E; Krishnamoorthy R; Toubert A; Charron D; Socié G; Tamouza R Blood; 2009 Dec; 114(25):5216-24. PubMed ID: 19786616 [TBL] [Abstract][Full Text] [Related]
11. Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease. Ben Chaaben A; Ouni N; Douik H; Ayari F; Abaza H; Mamoghli T; Harzallah L; Fortier C; Boukouaci W; Krishnamoorthy R; Charron D; Gara S; Guemira F; Tamouza R Immunol Invest; 2020 Jul; 49(5):498-509. PubMed ID: 31814472 [TBL] [Abstract][Full Text] [Related]
12. Association between CD226 polymorphism and soluble levels in rheumatoid arthritis: Relationship with clinical activity. Mosaad YM; El-Toraby EE; Tawhid ZM; Abdelsalam AI; Enin AF; Hasson AM; Shafeek GM Immunol Invest; 2018 Apr; 47(3):264-278. PubMed ID: 29319370 [TBL] [Abstract][Full Text] [Related]
14. A Valine Mismatch at Position 129 of Michita RT; Chies JAB; Schramm S; Horn PA; Heinemann FM; Wunsch A; Viebahn R; Schenker P; Rebmann V Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181474 [TBL] [Abstract][Full Text] [Related]
15. MICB*002 and MICB*014 protect against rheumatoid arthritis, whereas MICA*009 and MICA*A6 are associated with rheumatoid arthritis in a Hainan Han Chinese population. Wang Y; Li S; Chen C; Luo Q; Li Y; Liu L; Fu X; Yu P; Wang F Int J Rheum Dis; 2019 Jan; 22(1):90-95. PubMed ID: 29665245 [TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-G polymorphism influences the age of onset and autoantibody status in rheumatoid arthritis. Mariaselvam CM; Chaaben AB; Salah S; Charron D; Krishnamoorthy R; Tamouza R; Negi VS Tissue Antigens; 2015 Mar; 85(3):182-9. PubMed ID: 25656292 [TBL] [Abstract][Full Text] [Related]
17. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus. Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P Front Immunol; 2021; 12():633658. PubMed ID: 34012432 [TBL] [Abstract][Full Text] [Related]
18. MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study. Fechtenbaum M; Desoutter J; Delvallez G; Brochot E; Guillaume N; Goëb V Genes Immun; 2019 Sep; 20(7):599-605. PubMed ID: 30177859 [TBL] [Abstract][Full Text] [Related]
19. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk. Ouni N; Ben Chaaben A; Kablouti G; Lajnef M; Ayari F; Abaza H; Damak T; Harzallah L; Benammar-Elgaaeid A; Guemira F; Tamouza R Immunol Invest; 2017 Aug; 46(6):603-614. PubMed ID: 28742417 [TBL] [Abstract][Full Text] [Related]
20. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment. Marwa OS; Kalthoum T; Wajih K; Kamel H Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]